These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


702 related items for PubMed ID: 22825731

  • 1. Clinical features of polymyalgia rheumatica and giant cell arteritis.
    Salvarani C, Pipitone N, Versari A, Hunder GG.
    Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
    [Abstract] [Full Text] [Related]

  • 2. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J, Warrington KJ.
    Drugs Aging; 2011 Aug 01; 28(8):651-66. PubMed ID: 21812500
    [Abstract] [Full Text] [Related]

  • 3. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH.
    Prim Care; 2018 Jun 01; 45(2):305-323. PubMed ID: 29759126
    [Abstract] [Full Text] [Related]

  • 4. [Polymyalgia rheumatica and temporal arteritis].
    Vos PA, Bijlsma JW, Derksen RH.
    Ned Tijdschr Geneeskd; 2005 Aug 27; 149(35):1932-7. PubMed ID: 16159030
    [Abstract] [Full Text] [Related]

  • 5. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
    Chatelain D, Duhaut P, Loire R, Bosshard S, Pellet H, Piette JC, Sevestre H, Ducroix JP.
    Arthritis Rheum; 2008 Aug 27; 58(8):2565-73. PubMed ID: 18668584
    [Abstract] [Full Text] [Related]

  • 6. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA, García-Porrúa C, Vázquez-Caruncho M.
    J Rheumatol; 1998 Sep 27; 25(9):1750-5. PubMed ID: 9733456
    [Abstract] [Full Text] [Related]

  • 7. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD.
    J Rheumatol; 2009 Oct 27; 36(10):2269-76. PubMed ID: 19684157
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Mansalis K.
    FP Essent; 2016 Jan 27; 440():16-22. PubMed ID: 26734832
    [Abstract] [Full Text] [Related]

  • 11. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 27; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
    Emamifar A, Ellingsen T, Hermann AP, Hess S, Gerke O, Ahangarani Farahani Z, Syrak Hansen P, Jensen Hansen IM, Thye-Rønn P.
    Sci Rep; 2021 Mar 18; 11(1):6220. PubMed ID: 33737697
    [Abstract] [Full Text] [Related]

  • 13. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L, Spiera R.
    Best Pract Res Clin Rheumatol; 2018 Dec 18; 32(6):803-812. PubMed ID: 31427056
    [Abstract] [Full Text] [Related]

  • 14. Giant cell arteritis and polymyalgia rheumatica: an update.
    González-Gay MA, Pina T.
    Curr Rheumatol Rep; 2015 Feb 18; 17(2):6. PubMed ID: 25618572
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica.
    Zhang Y, Wang D, Chu X, Zhang W, Zeng X.
    Ir J Med Sci; 2019 May 18; 188(2):713-720. PubMed ID: 30251177
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J.
    Drugs Aging; 2006 May 18; 23(8):627-49. PubMed ID: 16964987
    [Abstract] [Full Text] [Related]

  • 19. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
    Jakobsson K, Jacobsson L, Mohammad AJ, Nilsson JÅ, Warrington K, Matteson EL, Turesson C.
    BMC Musculoskelet Disord; 2016 Aug 24; 17(1):363. PubMed ID: 27558589
    [Abstract] [Full Text] [Related]

  • 20. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C, Padoan R, Iorio L, Tomelleri A, Terrier B, Muratore F, Dasgupta B.
    Autoimmun Rev; 2024 Jan 24; 23(1):103415. PubMed ID: 37625672
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.